Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Marksans Pharma Ltd

NSE :MARKSANS   BSE :524404  Sector : Pharmaceuticals
Buy, Sell or Hold MARKSANS? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

18 Nov
309.35
(0.34%)
14 Nov
308.30
(0.85%)
13 Nov
305.70
(1.73%)
12 Nov
300.50
(4.12%)
11 Nov
288.60
(-3.61%)
08 Nov
299.40
(-0.71%)
07 Nov
301.55
(1.75%)
06 Nov
296.35
(2.00%)
05 Nov
290.55
(1.27%)
04 Nov
286.90
(-1.63%)
01 Nov
291.65
(0.69%)
31 Oct
289.65
(3.89%)
30 Oct
278.80
(2.14%)
29 Oct
272.95
(-0.53%)
28 Oct
274.40
(4.10%)
25 Oct
263.60
(-2.80%)
24 Oct
271.20
(0.39%)
23 Oct
270.15
(1.52%)
22 Oct
266.10
(-2.90%)
21 Oct
274.05
(-2.75%)
18 Oct
281.80
(-0.48%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish
Medium Term Investors

Neutral
Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bullish

302.31

10 DMA
Bullish

298.6

20 DMA
Bullish

286.89

50 DMA
Bullish

288.32

100 DMA
Bullish

245.35

200 DMA
Bullish

201.42


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 18, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 328.24 322.12 312.79 - -
R2 322.12 317.35 311.64 322.05 -
R1 315.74 314.4 310.5 315.6 318.93
P 309.62 309.62 309.62 309.55 311.21
S1 303.24 304.85 308.2 303.1 306.43
S2 297.12 301.9 307.06 297.05 -
S3 290.74 297.12 305.91 - -

Key Metrics

EPS

3.39

P/E

91.24

P/B

10.86

Dividend Yield

0.19%

Market Cap

14,019 Cr.

Face Value

1

Book Value

28.49

ROE

16.53%

EBITDA Growth

145.74 Cr.

Debt/Equity

0.1

Shareholding Pattern

  43.87% Total Promoter Holding
3.02% Mutual Fund Holdings
10.43% FIIs
30.71% Non Institution
0% Insurance Companies
0% Custodians
11.97% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Marksans Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 550.23 590.93 576.54 605.57 652.98
PROFIT 83.52 83.24 78.29 88.75 96.72
EPS 1.84 1.84 1.73 1.96 2.13

Marksans Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 220.6 242.69 237.39 262.68 339.98
PROFIT 31.29 25.29 32.99 32.02 63.2
EPS 0.69 0.56 0.73 0.71 1.39

Profit & Loss (Figures in Rs. Crores)


Marksans Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 801.33 897.36 822.12 900.61 1024.59 1081.59 1519.15 1519.79 1917.84 2301.69
PROFIT 109.46 78.5 8.83 32.98 76.46 120.73 235.92 184.57 266.52 313.59
EPS 2.71 1.99 0 0.87 1.97 2.95 5.83 4.56 5.85 6.95

Marksans Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 407.32 362.66 222.12 305.81 434.8 439.22 630.16 696.65 725.87 922.59
PROFIT 67.11 71.48 11.53 12.43 43.65 37.87 98.35 103.99 102.92 133.69
EPS 1.61 1.72 0.19 0.3 1.07 0.93 2.4 2.54 2.27 2.95

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 45.3245.3240.9340.9340.9340.9340.9340.9353.4353.43
Reserves Total 2,019.741,699.851,068.24845.56595.08501.55429.93392.5400.89326.33
Equity Share Warrants0093.10000000
Total Shareholders Funds2,065.061,745.171,202.27886.49636.01542.48470.86433.43454.32379.76
Minority Interest20.8519.9120.718.8613.1110.229.556.258.368.1
Secured Loans 29.0941.5941.2918.7418.89100.22117.96109.7187.988.59
Unsecured Loans 214.9781.3669.4915.3610.7600000
Total Debt244.06122.95110.7834.129.65100.22117.96109.7187.988.59
Other Liabilities4.563.251.867.116.4711.3611.0811.9600
Total Liabilities2,334.531,891.281,335.61946.56685.24664.28609.45561.35550.58476.45
APPLICATION OF FUNDS :
Gross Block 1,193.49828.26726.27551.93563.24506.26495.35456.49429.47297.78
Less: Accumulated Depreciation417.55341.95297.96242.56260.52236.54215.97189.52159.82131.89
Net Block775.94486.31428.31309.37302.72269.72279.38266.97269.65165.89
Capital Work in Progress9.429.872.5711.680000.3600
Investments 26.990.540.440.26000000
Inventories 617.94484.74424.44404.32241.84293.25218.12190.09167.79130.11
Sundry Debtors 453.18416.85394.78271.95243.35176.6176.91247.58217.29183.45
Cash and Bank Balance673.58714.96349.27212.1893.7333.5439.8825.1635.3185.27
Loans and Advances 90.858.2232.2814.1114.6628.0615.6321.0619.7610
Total Current Assets1,835.51,674.771,200.77902.56593.59531.44450.54483.89440.15508.83
Current Liabilities 313.94257.13268.82242.32165.9126.6687.35162.5119.66140.5
Provisions 21.8626.618.0531.8840.725.7429.3623.8551.8857.15
Total Current Liabilities & Provisions335.81283.73286.87274.19206.62132.41116.72186.35171.54197.65
Net Current Assets1,499.691,391.03913.9628.36386.96399.03333.82297.54268.61311.18
Deferred Tax Assets18.7711.829.162.093.22.783.012.644.761.52
Deferred Tax Liability29.3927.2122.939.3513.368.567.576.752.852.97
Net Deferred Tax-10.62-15.39-13.77-7.26-10.16-5.78-4.56-4.111.91-1.45
Other Assets33.1118.914.164.165.731.290.820.5910.410.83
Total Assets2,334.521,891.271,335.61946.56685.25664.27609.46561.36550.58476.46
Contingent Liabilities01.451.4519.7848.1730.410.47000
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 45.3245.3240.9340.9340.9340.9340.9340.9353.4353.43
Reserves Total 1,177.391,066.01650.64558.79464.69429.64388.04377.95369.27304.75
Equity Share Warrants0093.10000000
Total Shareholders Funds1,222.711,111.33784.67599.72505.62470.57428.97418.88422.7358.18
Secured Loans 00000.0577.6366.8673.2340.6249.93
Unsecured Loans 8.137.6914.3114.3710.7600000
Total Debt8.137.6914.3114.3710.8177.6366.8673.2340.6249.93
Other Liabilities4.473.181.867.116.4711.3611.0811.9600
Total Liabilities1,235.311,122.2800.84621.2522.9559.56506.91504.07463.32408.11
APPLICATION OF FUNDS :
Gross Block 472.78318.89301.34277.25246.62224.9201.83195.61184.48162.47
Less : Accumulated Depreciation 201.2174.95165.83148.17131.44122.28113.94101.6987.0172.45
Net Block 271.58143.94135.51129.08115.18102.6287.8993.9297.4790.02
Capital Work in Progress03.91000000.3600
Investments 292.75266.29236.51236.34236.07236.07236.07234.29231.4467.62
Inventories 190.85130.95103.6893.6974.670.3642.2929.2443.7451.03
Sundry Debtors 370.17305.49246.78168.93161.87177.83168.87154.8133.41124.63
Cash and Bank Balance312.23440.26224.05105.613.351.80.712.563.13167.54
Loans and Advances 47.4636.5214.922.894.2322.0120.6330.0123.7625.46
Total Current Assets920.71913.22589.43371.12244.05272.01232.51216.61204.04368.66
Current Liabilities 264.45206.71147.64100.8264.2944.2541.9221.3132.0878.06
Provisions 6.887.328.1210.181.791.142.4515.0438.4940.45
Total Current Liabilities & Provisions271.33214.03155.7611166.0845.3944.3736.3670.57118.51
Net Current Assets649.38699.19433.66260.11177.98226.62188.14180.25133.47250.15
Deferred Tax Assets21.870.890.430.840.610.610.581.521.52
Deferred Tax Liability11.4110.519.98.9211.647.646.625.921.832.02
Net Deferred Tax-9.41-8.64-9.01-8.49-10.8-7.03-6.01-5.34-0.31-0.5
Other Assets31.0117.54.164.164.471.290.820.591.250.83
Total Assets1,235.311,122.19800.83621.21522.9559.56506.91504.07463.32408.11
Contingent Liabilities01.451.45115.1140.3871.3511.0509.710

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...423.53
Depreciation74.27
Interest (Net)-22.58
P/L on Sales of Assets-0.09
P/L on Sales of Invest-0.05
Prov. and W/O (Net)5.16
P/L in Forex3.04
Total Adjustments (PBT and Ext...55.42
Operating Profit before Workin...478.95
Trade and 0ther Receivables-37.17
Inventories-112.67
Total Adjustments (OP before W...-126.19
Cash Generated from/(used in) ...352.76
Direct Taxes Paid-122.35
Total Adjustments(Cash Generat...-122.35
Cash Flow before Extraordinary...230.41
Net Cash from Operating Activi...230.41
Purchased of Fixed Assets-208.84
Sale of Fixed Assets0.85
Purchase of Investments-37
Sale of Investments11.05
Interest Received30.87
Net Cash used in Investing Act...-140.84
Of the Short Term Borrowings-12.5
Of Financial Liabilities-28.4
Dividend Paid-22.66
Interest Paid-5.17
Net Cash used in Financing Act...-68.73
Net Profit before Tax and Extr...171.89
Depreciation29.13
Interest (Net)-21.51
Dividend Received25.77
P/L on Sales of Assets-0.03
P/L on Sales of Invest-0.05
Prov. and W/O (Net)3.11
P/L in Forex3.04
Total Adjustments (PBT and Ext...-16.4
Operating Profit before Workin...155.5
Trade and 0ther Receivables-70.24
Inventories-59.9
Total Adjustments (OP before W...-82.68
Cash Generated from/(used in) ...72.82
Direct Taxes Paid-38.76
Total Adjustments(Cash Generat...-38.76
Cash Flow before Extraordinary...34.05
Net Cash from Operating Activi...34.05
Purchased of Fixed Assets-155.67
Sale of Fixed Assets0.33
Purchase of Investments-37
Sale of Investments11.05
Interest Received19.65
Net Cash used in Investing Act...-114.22
Of Financial Liabilities-3.56
Dividend Paid-22.66
Net Cash used in Financing Act...-26.22

Company Details

Registered Office
Address11th Flr GRANDEUR Oshiwara,
Veera Desai Extn Rd Andheri(W)
CityMumbai
StateMaharashtra
Pin Code400053
Tel. No.91-22-40012000
Fax. No.91-22-40012011
Emailcompanysecretary@marksanspharma.com ; info@marksan
Internethttp://www.marksanspharma.com
Registrars
Address11th Flr GRANDEUR Oshiwara
CityMumbai
StateMaharashtra
Pin Code400053
Tel. No.91-22-40012000
Fax. No.91-22-40012011
Emailcompanysecretary@marksanspharma.com ; info@marksan
Internethttp://www.marksanspharma.com
Management
Name Designation
Mark SaldanhaChairman & Managing Director
Harshavardhan PanigrahiCompany Sec. & Compli. Officer
Seetharama Raju BuddharajuNon-Exec. & Independent Dir.
Sandra SaldanhaWhole-time Director
Digant Mahesh ParikhNon-Exec. & Independent Dir.
Varddhman Vikramaditya JainWhole-time Director
Abhinna Sundar MohantyNon-Exec. & Independent Dir.
Sunny SharmaNon Executive Director
Shailaja VardhanIndependent Director